EUVIMEDEUVIMED entdecken
Open Access

Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population‐based registry study

Cecilia Ahlström Emanuelsson iD, Anders Ehnhage, Mats Holmström, Oskar Hagberg, Marit Westman

Journal of Internal Medicine · 2026

DOI: 10.1111/joim.70134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Cecilia Ahlström Emanuelsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Department of Ear, Nose and Throat Diseases, Skane University Hospital, Lund, Sweden. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic, Life Expectancy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fond för Morbus Oslerforskning vid Skånes universitetssjukhus..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant genetic disorder associated with substantial morbidity.

Objectives

The aim of this study was to estimate mortality in a country without centralized national care for HHT patients. Moreover, we identified causes of death and estimated the prevalence of HHT in Sweden.

Methods

The Swedish National Patient Register (NPR) was used to identify individuals with HHT using the International Classification of Diseases (ICD) code I78.0. Cases included all individuals with this code between January 1, 2001 and December 31, 2003 ( n = 393). Five age‐ and gender‐matched controls from the general population were selected by Statistics Sweden (SCB) ( n = 1965). Cases and controls were followed for survival until 2018 using the Swedish National Cause of Death Register (DORS). To calculate prevalence, we identified all individuals with the ICD code I78.0 in the NPR over 12 years, from January 1, 2007 to December 30, 2018.

Results

Life expectancy for cases with HHT after age 30 was estimated at 73.0 (68.0–77.2) compared to 80.5 (79.1–82.0) years for controls. Ischemic heart diseases, diseases of arteries, arterioles, capillaries, and liver diseases were significantly more common causes of death among HHT patients. The prevalence of HHT was estimated at 9.3 per 100,000 over the 12 years.

Conclusion

HHT in Sweden is associated with markedly shorter expected survival compared to the general population, and known complications of HHT are among the most common causes of death. The estimated prevalence of HHT in Sweden was relatively low, possibly due to underdiagnosis of those with milder symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Telangiectasia, Hereditary HemorrhagicLife ExpectancyHumansSwedenFemaleRegistriesMaleAgedMiddle AgedAged, 80 and overCause of DeathPrevalenceAdultCase-Control StudiesYoung AdultAdolescentInfant

Stichwörter der Autor:innen

Cause of deathHHT MethodsI 78.0Life expectancy beyond age 30Matched controlls ResultsPrevalence in Sweden DiscussionSweden shorter life ExpactanccySwedish National Patient Registrer (NPR)underdiagnosis

Autor:innen und Institutionen

  • Department of Clinical Science, Department of Ear, Nose and Throat Diseases, Skane University Hospital, Lund, Sweden.
  • Department of Clinical Science, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Stockholm, Sweden.
  • Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Department of Medicine, Huddinge, Clinical Lung- and Allergy Research Unit, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Cecilia Ahlström Emanuelsson

Förderung

  • Fond för Morbus Oslerforskning vid Skånes universitetssjukhus.

Zitieren

APA

Emanuelsson, C. A., Ehnhage, A., Holmström, M., Hagberg, O., & Westman, M. (2026). Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population‐based registry study. Journal of Internal Medicine. https://doi.org/10.1111/joim.70134

Vancouver

Emanuelsson CA, Ehnhage A, Holmström M, Hagberg O, Westman M. Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population‐based registry study. Journal of Internal Medicine. 2026. doi:10.1111/joim.70134

BibTeX
@article{Emanuelsson2026,
  author = {Emanuelsson, Cecilia Ahlström and Ehnhage, Anders and Holmström, Mats and Hagberg, Oskar and Westman, Marit},
  title = {Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population‐based registry study},
  journal = {Journal of Internal Medicine},
  year = {2026},
  doi = {10.1111/joim.70134}
}
Kostenlos starten →